The Ahmed valve in refractory pediatric glaucoma

Area of Science:

• Ophthalmology
• Pediatric Surgery
• Glaucoma Research

Background:

• Refractory glaucoma in pediatric patients presents significant challenges in intraocular pressure (IOP) management.
• Standard treatments may be insufficient, necessitating advanced surgical interventions.
• The Ahmed Glaucoma Valve (AGV) implant is a potential option for these complex cases.

Purpose of the Study:

• To evaluate the efficacy and safety of the Ahmed Glaucoma Valve implant in pediatric patients diagnosed with refractory glaucoma.
• To assess the long-term outcomes, including IOP control and complication rates.
• To investigate the influence of prior cycloablation procedures on surgical success.

Main Methods:

• Retrospective chart review of 27 eyes from 23 pediatric patients (<18 years) with refractory glaucoma.
• Primary outcome measure: time to surgical failure.
• Success defined as IOP ≤ 21 mm Hg without devastating complications or further glaucoma surgery.

Main Results:

• Mean preoperative IOP of 32.8 mm Hg reduced to 16.7 mm Hg at 18 months postoperatively.
• Overall success rate of 85.2% at last follow-up; 90.6% at 12 months and 58.3% at 24 months.
• Previous cycloablation was associated with lower postoperative IOP and reduced medication dependence.

Conclusions:

• Ahmed Glaucoma Valve implantation is an effective therapy for pediatric refractory glaucoma.
• The AGV implant can be safely used in eyes with uncontrolled IOP despite prior cycloablation.
• This surgical approach offers a viable solution for managing complex pediatric glaucoma cases.